Bleomycin causes DNA damage in colon cancer (HCT116 and HT29) cells accompanied by downregulation of AKT1 protein expression, which is reversed by p53 and miR-374b knockdown [42]. The gene discussed is TP53; the disease is malignant colon neoplasm.